DSGN   $5.61  0.72% Market Closed After Close 5.62 0.18%

Design Therapeutics Inc
Total Cash 261.02M
totalCashPerShare 4.61
EBITDA -62.82M
Total Debt 2.70M
quickRatio 41.041
currentRatio 41.42
Total Revenue
debtToEquity 1.035
Revenue/Share
ROA -0.13632
ROE -0.18110001
grossProfits
freeCashflow -33.75M
operatingCashflow -51.03M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 56.50M
forwardPE -5.0769234
floatShares 25.24M
sharesOutstanding 56.62M
sharesShort 2.62M
sharesShortPriorMonth 2.59M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.36%
heldPercentInstitutions 0.55%
Short Ratio help_outline 13.18%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 4.614
Price To Book help_outline 1.29
earningsQuarterlyGrowth
netIncomeToCommon -50.53M
trailingEps -0.90%
forwardEps -1.17%
enterpriseToEbitda -0.90
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.24 3Q 2024
institutionsCount 132
lastUpdated Nov. 7, 2024, 4:59 a.m.